How to Improve Drug Safety Literature Screening Compliance

Correctly identifying adverse events from medical literature is one of the key tasks in pharmacovigilance (PV). It’s also one of the most complex. The sheer volume of information available is overwhelming: so much so that even in the most precisely constructed searches, only five percent of references retrieved will be relevant. Then there’s the issue of duplicate articles, which on average, account for around one-third of references retrieved. Medical literature monitoring has an additional layer of complexity, added by the processes and software used to carry out the task more efficiently. Here, regulations demand high levels of rigour and quality management, with both people and technology required to operate to detailed and demanding standards.

Our on-demand webinar looks at these three key areas – search, duplicate references and quality and validation – and provides advice and guidance on how you can optimise each of these elements of the medical literature monitoring process. In this on-demand webinar, we discuss:

- The key regulatory guidelines and how they affect the medical literature monitoring process
- The impact that literature searching has on the entire drug safety monitoring workflow
- How to make the literature review process more efficient by removing duplicate references
- The importance of using validated software for literature review

For more information about our end-to-end, modular pharmacovigilance literature monitoring solution, visit: https://dialog.com/what-we-do/pharmac...